X-151955379-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004961.4(GABRE):āc.1126A>Gā(p.Lys376Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000107 in 1,210,073 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_004961.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRE | NM_004961.4 | c.1126A>G | p.Lys376Glu | missense_variant | 8/9 | ENST00000370328.4 | NP_004952.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRE | ENST00000370328.4 | c.1126A>G | p.Lys376Glu | missense_variant | 8/9 | 1 | NM_004961.4 | ENSP00000359353 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000893 AC: 1AN: 111965Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34139
GnomAD4 exome AF: 0.0000109 AC: 12AN: 1098108Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 3AN XY: 363462
GnomAD4 genome AF: 0.00000893 AC: 1AN: 111965Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34139
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 23, 2023 | The c.1126A>G (p.K376E) alteration is located in exon 8 (coding exon 8) of the GABRE gene. This alteration results from a A to G substitution at nucleotide position 1126, causing the lysine (K) at amino acid position 376 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at